1 drug(s) with this reaction
290 total reports
Abdominal Pain Upper has been reported as an adverse reaction across 1 drug(s) manufactured by Ipsen Biopharmaceuticals Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 290 adverse event reports mention abdominal pain upper in connection with Ipsen Biopharmaceuticals Inc products.
This page provides a breakdown of which Ipsen Biopharmaceuticals Inc drugs are most commonly associated with abdominal pain upper, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Ipsen Biopharmaceuticals Inc drugs have abdominal pain upper listed in their FDA adverse event reports, sorted by report count:
In addition to abdominal pain upper, the following adverse reactions have been reported across Ipsen Biopharmaceuticals Inc's drug portfolio:
1 drug(s) manufactured by Ipsen Biopharmaceuticals Inc have abdominal pain upper listed in their FDA adverse event reports: LANREOTIDE ACETATE.
There are a combined 290 reports of abdominal pain upper across 1 Ipsen Biopharmaceuticals Inc drug(s) in the FDA adverse event database.